The Movement Disorder of Brain-Lung-Thyroid Syndrome Can be Responsive to Methylphenidate Cover

The Movement Disorder of Brain-Lung-Thyroid Syndrome Can be Responsive to Methylphenidate

Tremor and Other Hyperkinetic Movements

Volume 7 (2017): Issue 0

By: Laurence Gauquelin, Luan T. Tran, Sylvain Chouinard and Geneviève Bernard

Open Access

|Oct 2017

Figures & Tables

Video 1

Immediate Improvement of the Involuntary Movements with Methylphenidate. The patient executed the following tasks prior to and 30 minutes after methylphenidate hydrochloride administration: running, performing rapid alternating movements, pouring water into a cup, and writing a series of loops with her dominant hand. There was a significant reduction in her choreic movements and dystonic postures, especially in the limbs. All tasks were carried out faster and with more precision after receiving her medication.

DOI: https://doi.org/10.5334/tohm.372 | Journal eISSN: 2160-8288

Journal RSS Feed

Language: English

Submitted on: Aug 29, 2017

Accepted on: Oct 9, 2017

Published on: Oct 26, 2017

Published by: Columbia University Libraries/Information Services

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

brain-lung-thyroid syndrome,

NKX2-1-related disorder,

psychostimulant,

methylphenidate

© 2017 Laurence Gauquelin, Luan T. Tran, Sylvain Chouinard, Geneviève Bernard, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 7 (2017): Issue 0 Next article